Citations

Clear

4610 citation(s) found for "Lu, Brian".

Clinical Characteristics and Outcomes Among Individuals With Spinal Implant Infections: A Descriptive Study
Baxi, Sanjiv M. , Robinson, Makeda , Grill, Marie , Doernberg, Sarah B. , Liu, Catherine , Grill, Marie F, Schwartz, Brian S.

Mayo Clinic

Open Forum Infectious Diseases | August 31, 2016 | Volume: 3 | Issue: 3 | Pages: No page available

10.1093/ofid/ofw177 | PMID 27704027 Get It

Abstract Little is known about the clinical presentation and outcomes associated with spinal implant infections. Here, we describe a single center's experience in a retrospective cohort of 109 individuals with spinal implant infections, including clinical, microbiological, therapeutic, and outcome data.
The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury
Hirshman, Brian R. , McCutcheon, Brandon A., Tringale, Kathryn R. , Carroll, Kate , Richtand, Neil M., Chen, Clark C. , Brandel, Michael G. , Perry, William , Carter, Bob S.

Mayo Clinic

Journal of Neurotrauma | August 29, 2016 | Volume: 34 | Issue: 5 | Pages: 1005-1016

10.1089/neu.2016.4504 | PMID 27573722 Get It

It is well established that traumatic brain injury (TBI) is associated with the development of psychiatric disorders. However, the impact of psychiatric disorders on TBI outcome is less well understood. We examined the outcomes of patients who experienced a traumatic subdural hemorrhage and whether a comorbid psychiatric disorder was associated with a change in outcome. A retrospective observational study was performed in the California Office of Statewide Health Planning and Development (OSHPD) and the Nationwide Inpatient Sample (NIS). Patients hospitalized for acute subdural hemorrhage were identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes. Patients with coexisting psychiatric diagnoses were identified. Outcomes studied included mortality and adverse discharge disposition. In OSPHD, diagnoses of depression (OR = 0.64, p < 0.001), bipolar disorder (OR = 0.45, p < 0.05), and anxiety (OR = 0.37, p < 0.001) were associated with reduced mortality during hospitalization for TBI, with a trend toward psychosis (OR = 0.56, p = 0.08). Schizophrenia had no effect. Diagnoses of psychosis (OR = 2.12, p < 0.001) and schizophrenia (OR = 2.60, p < 0.001) were associated with increased adverse discharge. Depression and bipolar disorder had no effect, and anxiety was associated with reduced adverse discharge (OR = 0.73, p = 0.01). Results were confirmed using the NIS. Analysis revealed novel associations between coexisting psychiatric diagnoses and TBI outcomes, with some subgroups having decreased mortality and increased adverse discharge. Potential mechanisms include pharmacological effects of frequently prescribed psychiatric medications, the pathophysiology of individual psychiatric disorders, or under-coding of psychiatric illness in the most severely injured patients. Because pharmacological mechanisms, if validated, might lead to improved outcome in TBI patients, further studies may provide significant public health benefit.
Assessment of the Interrater Reliability of the Congress of Neurological Surgeons Microanastomosis Assessment Scale
Alghoul, Mohammed S., Hamade, Youssef J. , Sattur, Mithun G. , Aoun, Rami James N. , Halasa, Tariq K., Krishna, Chandan , Zammar, Samer G. , Tecle, Najib E. El , Aoun, Salah G. , Ragel, Brian T. , Resnick, Daniel K. , Lonser, Russell R. , Pines, Andrew R. , Ahmadieh, Tarek Y. El , Byrne, Richard W. , Harrop, James Shields , Selden, Nathan R. W. , Bendok, Bernard R.

Mayo Clinic

Operative Neurosurgery | August 23, 2016 | Volume: 13 | Issue: 1 | Pages: 108-112

10.1227/neu.0000000000001403 | PMID 28931262 Get It

Abstract BACKGROUND: The potential for simulation-based learning in neurosurgical training has led the Congress of Neurosurgical Surgeons to develop a series of simulation modules. The Northwestern Objective Microanastomosis Assessment Tool (NOMAT) was created as the corresponding assessment tool for the Congress of Neurosurgical Surgeons Microanastomosis Module. The face and construct validity of the NOMAT have been previously established. OBJECTIVE: To further validate the NOMAT by determining its interrater reliability (IRR) between raters of varying levels of microsurgical expertise. METHODS: The NOMAT was used to assess residents’ performance in a microanastomosis simulation module in 2 settings: Northwestern University and the Society of Neurological Surgeons 2014 Boot Camp at the University of Indiana. At Northwestern University, participants were scored by 2 experienced microsurgeons. At the University of Indiana, participants were scored by 2 postdoctoral fellows and an experienced microsurgeon. The IRR of NOMAT was estimated by computing the intraclass correlation coefficient using SPSS v22.0 (IBM, Armonk, New York). RESULTS: A total of 75 residents were assessed. At Northwestern University, 21 residents each performed microanastomosis on 2 model vessels of different sizes, one 3 mm and one 1 mm. At the University of Indiana, 54 residents performed a single microanastomosis procedure on 3-mm vessels. The intraclass correlation coefficient of the total NOMAT scores was 0.88 at Northwestern University and 0.78 at the University of Indiana. CONCLUSION: This study indicates high IRR for the NOMAT. These results suggest that the use of raters with varying levels of expertise does not compromise the precision or validity of the scale. This allows for a wider adoption of the scale and, hence, a greater potential educational impact.
Does early (treatment in) BENEFIT lead to late MS benefit?
Healy, Brian C. , Weinshenker, Brian G. , Weinshenker, Brian G

Mayo Clinic

Neurology | August 16, 2016 | Volume: 87 | Issue: 10 | Pages: 970-971

10.1212/wnl.0000000000003070 | PMID 27511185 Get It

Central canal enhancement and the trident sign in spinal cord sarcoidosis
Zalewski, Nicholas L. , Krecke, Karl N. , Weinshenker, Brian G. , Aksamit, Allen J. , Conway, Brittani L., McKeon, Andrew , Flanagan, Eoin P. , Flanagan, E P , Weinshenker, Brian G , McKeon, Andrew

Mayo Clinic

Neurology | August 15, 2016 | Volume: 87 | Issue: 7 | Pages: 743-744

10.1212/wnl.0000000000002992 | PMID 27527540 Get It

Novel porous poly(propylene fumarate‐co‐caprolactone) scaffolds fabricated by thermally induced phase separation
Guo, Ji, Liu, Xifeng , Waletzki, Brian E., Yaszemski, Michael J. , Lu, Lichun , Miller, Alan Lee

Mayo Clinic

Journal of Biomedical Materials Research Part A | August 11, 2016 | Volume: 105 | Issue: 1 | Pages: 226-235

10.1002/jbm.a.35862 | PMID 27513282 Get It

AbstractScaffolds with porous structures are highly applicable for tissue engineering and regenerative medicine. In the present study, 3‐dimensional poly(propylene fumarate‐co‐caprolactone) [P(PF‐co‐CL)] scaffolds were fabricated from a P(PF‐co‐CL)–dioxane‐water ternary system through thermally induced phase separation (TIPS). Cloud points of P(PF‐co‐CL) in dioxane‐water solutions increased with increased solute concentration, but increased dioxane composition decreased cloud point. Among 3 polymer concentrations (4, 8, and 12 wt%), 8 wt% P(PF‐co‐CL) scaffolds exhibited the best pore interconnectivity, with large, regular sized pores. Scaffolds were formed in 3 solutions with different dioxane‐water ratios (74/26, 78/22, and 82/18 wt/wt); the 78/22 wt/wt scaffold had finger‐shaped patterns with better interconnectivity than scaffolds from the other two ratios. Higher dioxane‐water ratios resulted in a larger contact angle and thus less wettability for the fabricated scaffold, while scaffolds fabricated from higher concentrations of P(PF‐co‐CL) or high dioxane‐water ratios had better biomineralization after soaking in simulated body fluid. In vitro cell viability testing showed the scaffolds had good biocompatibility with both bone and nerve cells. The results indicate that the polymer concentration and solvents ratio significantly affect the formation of porous structures, and optimum processing parameters were found to be 8% polymer concentration and 22% to 24% water content. These porous P(PF‐co‐CL) scaffolds fabricated via TIPS may be useful in various tissue engineering applications © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 226–235, 2017.
Stereotactic Radiosurgery for Cystic Vestibular Schwannomas
Frisch, Christopher D., Jacob, Jeffrey T. , Carlson, Matthew L. , Foote, Robert L. , Driscoll, Colin L. W., Neff, Brian A., Pollock, Bruce E. , Link, Michael J.

Mayo Clinic

Neurosurgery | August 10, 2016 | Volume: 80 | Issue: 1 | Pages: 112-118

10.1227/neu.0000000000001376 | PMID 27509069 Get It

Abstract BACKGROUND: The optimum treatment for cystic vestibular schwannoma (VS) remains controversial. Anecdotally, many treating physicians feel that cystic VSs do not respond to stereotactic radiosurgery (SRS) as well as noncystic tumors. OBJECTIVE: To present outcomes after treatment of predominantly cystic VS with SRS. METHODS: A prospectively maintained clinical database of patients undergoing Gamma Knife (Elekta Instruments, Stockholm, Sweden) radiosurgery (GKRS) for VS at a single tertiary academic referral center was retrospectively reviewed. Patients diagnosed with cystic VS who were treated with GKRS between 1997 and 2014 were analyzed. Size-matched solid tumors treated with GKRS during this period were selected as controls. RESULTS: Twenty patients (12 women; median age at treatment, 56 years; range, 36-85 years) with cystic VS met inclusion criteria. The median radiologic follow-up within the cystic group was 63 months (range, 17-201 months), and the median change in tumor size was −4.9 mm (range, −10.4 to 9.3 mm). Sixteen tumors (80%) shrank, 2 (10%) remained stable, and 2 (10%) enlarged, accounting for a tumor control rate of 90%. The median radiologic follow-up in the noncystic control group was 67 months (range, 6-141 months), and the median change in size was −2.0 mm (range, −10.4 to 2.5 mm). Tumor control in the solid group was 90%. Comparing only those tumors that decreased in size showed that there was a trend toward a greater reduction within the cystic group ( P = .05). CONCLUSION: The present study demonstrates that tumor control after SRS for cystic VS may not differ from that of noncystic VS in selected cases.
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma
Hu, Leland , Ning, Shuluo , Eschbacher, Jennifer , Baxter, Leslie C. , Gaw, Nathan , Ranjbar, Sara , Plasencia, Jonathan D. , Dueck, Amylou C. , Peng, Sen, Smith, Kris A. , Karis, John P. , Quarles, C. Chad , Loftus, Joseph C. , Jenkins, Robert B. , Sicotte, Hugues , Kollmeyer, Thomas M. , Elmquist, William F. , Frakes, David , Swanson, Kristin R. , Tran, Nhan L. , Mitchell, J. Ross , Eschbacher, Jennifer M., Plasencia, Jonathan, Nakaji, Peter , O'Neill, Brian P, Elmquist, William, Hoxworth, Joseph M. , Sarkaria, Jann, Dueck, A. C. , Baxter, Leslie C. , Wu, Teresa , O’Neill, Brian Patrick , Sarkaria, Jann N. , Swanson, Kristin R , Li, Jing , Kollmeyer, Thomas , Tran, Nhan L

Mayo Clinic

Neuro-Oncology | August 9, 2016 | Volume: 19 | Issue: 1 | Pages: 128-137

10.1093/neuonc/now135 | PMID 27502248 Get It

AbstractBackgroundGlioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comprises multiple genetically distinct clonal populations with different therapeutic sensitivities. This has implications for targeted therapy and genetically informed paradigms. Contrast-enhanced (CE)-MRI and conventional sampling techniques have failed to resolve this heterogeneity, particularly for nonenhancing tumor populations. This study explores the feasibility of using multiparametric MRI and texture analysis to characterize regional genetic heterogeneity throughout MRI-enhancing and nonenhancing tumor segments.MethodsWe collected multiple image-guided biopsies from primary GBM patients throughout regions of enhancement (ENH) and nonenhancing parenchyma (so called brain-around-tumor, [BAT]). For each biopsy, we analyzed DNA copy number variants for core GBM driver genes reported by The Cancer Genome Atlas. We co-registered biopsy locations with MRI and texture maps to correlate regional genetic status with spatially matched imaging measurements. We also built multivariate predictive decision-tree models for each GBM driver gene and validated accuracies using leave-one-out-cross-validation (LOOCV).ResultsWe collected 48 biopsies (13 tumors) and identified significant imaging correlations (univariate analysis) for 6 driver genes: EGFR, PDGFRA, PTEN, CDKN2A, RB1, and TP53. Predictive model accuracies (on LOOCV) varied by driver gene of interest. Highest accuracies were observed for PDGFRA (77.1%), EGFR (75%), CDKN2A (87.5%), and RB1 (87.5%), while lowest accuracy was observed in TP53 (37.5%). Models for 4 driver genes (EGFR, RB1, CDKN2A, and PTEN) showed higher accuracy in BAT samples (n = 16) compared with those from ENH segments (n = 32).ConclusionMRI and texture analysis can help characterize regional genetic heterogeneity, which offers potential diagnostic value under the paradigm of individualized oncology.
Decision Support Tool to Improve Glucose Control Compliance After Cardiac Surgery
Fedosov, Vitali, Dziadzko, Mikhail , Brown, Daniel R. , Pickering, Brian W. , Herasevich, Vitaly , Dearani, Joseph A. , Herasevich, Vitaly

Mayo Clinic

AACN Advanced Critical Care | August 4, 2016 | Volume: 27 | Issue: 3 | Pages: 274-282

10.4037/aacnacc2016634 | PMID 27959310 Get It

Hyperglycemia control is associated with improved outcomes in patients undergoing cardiac surgery. The Surgical Care Improvement Project metric (SCIP-inf-4) was introduced as a performance measure in surgical patients and included hyperglycemia control. Compliance with the SCIP-inf-4 metric remains suboptimal. A novel real-time decision support tool (DST) with guaranteed feedback that is based on the existing electronic medical record system was developed at a tertiary academic center. Implementation of the DST increased the compliance rate with the SCIP-inf-4 from 87.3% to 96.5%. Changes in tested clinical outcomes were not observed with improved metric compliance. This new framework can serve as a backbone for development of quality control processes for other metrics. Further and, ideally, multicenter studies are required to test if implementation of electronic DSTs will translate into improved resource utilization and outcomes for patients.
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes
Psutka, Sarah P. , Heidenreich, Mark J. , Boorjian, Stephen A. , Bailey, George C., Cheville, John C. , Stewart‐Merrill, Suzanne B., Lohse, Christine M. , Atwell, Thomas D. , Costello, Brian A. , Leibovich, Bradley C. , Thompson, R. Houston, Heidenreich, Mark, Psutka, Sarah P

Mayo Clinic

BJU International | August 4, 2016 | Volume: 119 | Issue: 1 | Pages: 116-127

10.1111/bju.13620 | PMID 27489013 Get It

Objectives To describe the clinicopathological features associated with increased risk of renal fossa recurrence ( RFR ) after radical nephrectomy ( RN ) and to describe the prognostic features associated with cancer‐specific survival ( CSS ) among patients with RFR treated with primary locally directed therapy, systemically directed therapy or expectant management. Patients and Methods The records of 2 502 patients treated with RN for unilateral, sporadic, localized renal cell carcinoma ( RCC ) between 1970 and 2006 were reviewed. CSS after RFR was estimated using the Kaplan–Meier method. Associations with the development of RFR and CSS after RFR were evaluated using Cox proportional hazards regression models. Results A total of 33 (1.3%) patients developed isolated RFR ( iRFR ) and 30 (1.2%) patients developed RFR in the setting of synchronous metastases after RN (study cohort, N = 63). The median follow‐up for the series was 9.0 years after RN and 6.0 years after RFR diagnosis. On multivariable analysis, advanced pathological stage ( pT 2: hazard ratio [ HR ] 4.36, P = 0.004; pT 3/4: HR 4.39, P = 0.003) and coagulative necrosis ( HR 2.71, P = 0.006) were independently associated with increased risk of iRFR . The median time to recurrence was 1.5 years after RN among the 33 patients with iRFR , and 1.4 years among all patients. Overall, the median CSS was 2.5 years after diagnosis of iRFR , 1.3 years after RFR in the setting of synchronous metastases, and 2.2 years overall. After primary locally directed therapy (surgery, ablation or radiation), systemic therapy or expectant management, the 3‐year CSS rates among patients with iRFR were 63%, 50% and 13% ( P = 0.001) and were 64%, 50% and 28% ( P = 0.006) among all patients, respectively. On multivariable analysis, when compared with observation, locally directed therapies were associated with a significantly decreased risk of death from RCC ( HR 0.26, P < 0.001). Conclusions Renal fossa recurrence is a rare event after RN for RCC and portends a poor prognosis, even in the absence of synchronous metastases. Development of iRFR is associated with advanced stage and aggressive tumour biology. Patients who underwent primary locally directed therapy had superior CSS compared with those treated with expectant management, supporting the use of aggressive local treatment in carefully selected patients with RFR . Future research is needed to determine the optimum role and sequencing of combined therapy in patients with this rare entity.